"40-50% increase in circulating BECLIN-1 levels by days 60-90, alongside a more than two-fold reduction in phosphorylated ATG13 at serine-258" (opens in new tab)

Healthspan What a Human Trial of Rapamycin in Chronic Fatigue Syndrome Reveals About... Speak to a doctor about longevity protocols and prescriptions. 1 post - 1 participant